LifeArc and Medicines Discovery Catapult have established this 3-year initiative to accelerate early-stage innovation in antimicrobial resistance (AMR). Without action

Innovate UK, LifeArc and Medicines Discovery Catapult to accelerate early-stage innovation in antimicrobial resistance (AMR). PACE will focus on removing barriers and connecting the AMR ecosystem to accelerate and strengthen the pre-clinical AMR pipeline. The initiative aims to establish a platform for UK-based early-stage research and development (R&D) projects in medicine discovery and diagnostics, making them more attractive for investment…